The abstract is read at the publisher; the summary is JClub's.
In bladder cancer, a SPINK1-high epithelial (E2) and TPM2-high CAF (C1) niche is linked to metabolic cooperation and immune restriction, with Spink1 loss improving PD-1 blockade outcomes.
- Why it matters: Spatial tumor–stroma organization can reshape metabolism and suppress immunity, but the specific niche-level circuits driving immune restriction in BLCA remain unclear.
- What they did: The study used spatial transcriptional programs to define single-cell states, inferred metabolic reactions and spatial metabolite distributions, and tested Spink1 loss in vivo alongside PD-1 blockade.
- The result: Spink1 perturbation altered extracellular glutamine and lactate, and in vivo Spink1 loss attenuated tumor progression while increasing cytotoxic CD8 T-cell infiltration and enhancing tumor control during PD-1 blockade.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.